These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 29171670

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN, Chen X, Foda HD, Smaldone GC, Hasaneen NA.
    Respir Res; 2019 Sep 11; 20(1):206. PubMed ID: 31511015
    [Abstract] [Full Text] [Related]

  • 24. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
    Liu J, Song C, Xiao Q, Hu G, Tao L, Meng J.
    Shock; 2015 Feb 11; 43(2):201-7. PubMed ID: 25394239
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Transient Receptor Potential Ankyrin 1 Channel Alters Transforming Growth Factor Beta 1/Smad Signaling in Rat Vocal Fold Fibroblasts.
    Matsushita H, Mukudai S, Hashimoto K, Kaneko M, Sugiyama Y, Branski RC, Hirano S.
    Laryngoscope; 2024 Nov 11; 134(11):4593-4598. PubMed ID: 38860441
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of human vocal fold fibroblasts derived from chronic scar.
    Jetté ME, Hayer SD, Thibeault SL.
    Laryngoscope; 2013 Mar 11; 123(3):738-45. PubMed ID: 23444190
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vocal fold myofibroblast profile of scarring.
    Branco A, Bartley SM, King SN, Jetté ME, Thibeault SL.
    Laryngoscope; 2016 Mar 11; 126(3):E110-7. PubMed ID: 26344050
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Down-regulation of miR-21-5p by pirfenidone to inhibit fibroblast proliferation in the treatment of acquired tracheal stenosis.
    Li W, Huang P, Wei J, Tan S, Liu G, Yang Q, Wang G.
    Clin Respir J; 2024 Jan 11; 18(1):e13727. PubMed ID: 38151323
    [Abstract] [Full Text] [Related]

  • 35. Effects of transforming growth factor-beta1 on human vocal fold fibroblasts.
    Branski RC, Barbieri SS, Weksler BB, Saltman B, Krishna P, Kraus DH, Broadbelt NV, Chen J, Poppas DP, Felsen D.
    Ann Otol Rhinol Laryngol; 2009 Mar 11; 118(3):218-26. PubMed ID: 19374154
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts.
    Lim X, Bless DM, Muñoz-Del-Río A, Welham NV.
    Ann Otol Rhinol Laryngol; 2008 Mar 11; 117(3):227-38. PubMed ID: 18444484
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Antifibrotic effect of pirfenidone on orbital fibroblasts in patients with thyroid-associated ophthalmopathy and its mechanisms].
    Li DD, Liu Y, Yuan RR, Yu T, Yang B, Pang WY.
    Zhonghua Nei Ke Za Zhi; 2019 Mar 01; 58(3):185-190. PubMed ID: 30803176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.